Search results for "TUMORS"

showing 10 items of 1138 documents

Myoepithelial cells are the main component in pleomorphic adenomas?

2007

Objective: The aim of this study was to quantify by immunohistochemistry the number of myoepithelial cells (MyECs) in pleomorphic adenomas (PAs). Material and methods: We retrieved the paraffin cubes of 27 PAs, new slides were done and they were stained with anti-S100 protein antibody. The amount of S-100 protein positive cells was quantified, their morphology was recorded and comparison among MyEC number with age, gender and involved gland were also done. Results: With S-100 protein, MyECs in normal salivary gland tissue were seen surrounding the ductual structures only. In the analysed PAs a mean of 27.4% of the neoplastic cells were positive to the antibody. With the exception of one PA,…

Adenoma pleomorfoUNESCO::CIENCIAS MÉDICASsalivary gland tumorscélulas mioepitelialestumores de glándulas salivales:CIENCIAS MÉDICAS [UNESCO]proteína S-100Pleomorphic adenomasmyoepithelial cellsS-100 protein
researchProduct

WNT2 activation through proximal germline deletion predisposes to small intestinal neuroendocrine tumors and intestinal adenocarcinomas

2021

Abstract Many hereditary cancer syndromes are associated with an increased risk of small and large intestinal adenocarcinomas. However, conditions bearing a high risk to both adenocarcinomas and neuroendocrine tumors are yet to be described. We studied a family with 16 individuals in four generations affected by a wide spectrum of intestinal tumors, including hyperplastic polyps, adenomas, small intestinal neuroendocrine tumors, and colorectal and small intestinal adenocarcinomas. To assess the genetic susceptibility and understand the novel phenotype, we utilized multiple molecular methods, including whole genome sequencing, RNA sequencing, single cell sequencing, RNA in situ hybridization…

AdenomaAcademicSubjects/SCI01140DOMAINSadenokarsinoomaCANCER-RISKIn situ hybridizationsuolistosyövätAdenocarcinomaBiologyNeuroendocrine tumorsGermlineWnt2 Proteinperinnöllinen alttius03 medical and health sciences0302 clinical medicineWNT2GeneticsGenetic predispositionmedicineHumansIntestinal MucosaMUTATIONMolecular BiologyGenetics (clinical)030304 developmental biologypaksusuolisyöpäCARCINOID-TUMORS0303 health sciencesperinnölliset tauditCYSTIC-FIBROSISGeneral MedicineNATIONWIDEmedicine.diseaseIntestinal epithelium3. Good healthGENOMENeuroendocrine TumorsHyperplastic PolypSingle cell sequencing3121 General medicine internal medicine and other clinical medicine030220 oncology & carcinogenesisMAPCancer researchsyöpätaudit3111 BiomedicineGeneral Articlegeneettiset tekijätColorectal Neoplasms
researchProduct

Value of Quantitative DNA Analysis in Endocrine Tumors of the Pancreas

1997

The diagnosis of malignancy can be difficult in endocrine tumors of the pancreas. Moreover prognostically relevant factors are not available. The aim of this study was to evaluate retrospectively whether the DNA distribution pattern can differentiate between benign and malignant pancreatic endocrine tumors and secondly whether the DNA content of tumor cells gives prognostic information.Image cytometry of paraffin-embedded tumor material of 42 pancreatic endocrine tumors.In 27 benign endocrine pancreatic tumors (25 insulinomas, 2 benign nonfunctioning endocrine tumors) we could differentiate between 6 diploid, 15 hypotriploid and 6 triploid DNA histograms. In 15 malignant endocrine tumors of…

AdenomaAdultMaleCancer ResearchPathologymedicine.medical_specialtyPancreatic diseaseAdolescentBiologyMalignancychemistry.chemical_compoundmedicineHumansEndocrine systemEndocrine pancreatic tumorsAgedRetrospective StudiesPloidiesfungifood and beveragesDNA NeoplasmGeneral MedicineMiddle AgedAdenoma Islet CellPrognosismedicine.diseasePancreatic Neoplasmsmedicine.anatomical_structureOncologychemistryFemaleInsulinomaPancreasDNAOncology
researchProduct

The Small Size and Superficial Location Suggest That Laparoscopic Partial Nephrectomy Is the First Choice for the Treatment of Juxtaglomerular Cell T…

2021

BackgroundJuxtaglomerular cell tumor (JGCT) is a very rare disease, and surgical resection is the only possible way to cure this tumor. Open nephrectomy and partial nephrectomy have been reported to manage JGCTs with excellent results in the previous reviews. Laparoscopic surgery has been popularized in recent years, while critical issues associated with laparoscopic surgical management have been seldom reported. We summarized the JGCTs in our center to discover the optimal surgical management and its anatomic foundation.MethodsIn this retrospective study, we enrolled a total of 14 JGCT patients. All patients received surgeries and were followed up for up to 11 years. We mainly summarized t…

AdenomaAdultMaleLaparoscopic surgerymedicine.medical_specialtyAdolescentEndocrinology Diabetes and Metabolismmedicine.medical_treatmentsuperficial location030204 cardiovascular system & hematologyNephrectomyPlasma renin activityDiseases of the endocrine glands. Clinical endocrinologysmall sizeYoung Adult03 medical and health sciencesEndocrinologyPostoperative Complications0302 clinical medicinemedicineHumansCarcinoma Renal CellOriginal ResearchAgedRetrospective Studieslaparoscopic partial nephrectomybusiness.industryRetrospective cohort studyjuxtaglomerular cell tumorsMiddle AgedRC648-665medicine.diseaseMagnetic Resonance ImagingKidney NeoplasmsHypokalemiaNephrectomySurgeryBlood pressure030220 oncology & carcinogenesisFemaleLaparoscopymedicine.symptombusinessJuxtaglomerular cell tumorlaparoscopic ultrasoundRare diseaseFrontiers in Endocrinology
researchProduct

MEN1 Disease Occurring Before 21 Years Old: A 160-Patient Cohort Study From the Groupe d'étude des Tumeurs Endocrines

2015

Multiple endocrine neoplasia Type-1 (MEN1) in young patients is only described by case reports.To improve the knowledge of MEN1 natural history before 21 years old.Obtain a description of the first symptoms occurring before 21 years old (clinical symptoms, biological or imaging abnormalities), surgical outcomes related to MEN1 Neuro Endocrine Tumors (NETs) occurring in a group of 160 patients extracted from the "Groupe d'étude des Tumeurs Endocrines" MEN1 cohort.The first symptoms were related to hyperparathyroidism in 122 cases (75%), pituitary adenoma in 55 cases (34%), nonsecreting pancreatic tumor (NSPT) in 14 cases (9%), insulinoma in 20 cases (12%), gastrinoma in three cases (2%), mal…

AdenomaAdultMalemedicine.medical_specialtyAdolescentendocrine system diseasesAdenomaEndocrinology Diabetes and MetabolismClinical BiochemistryAdrenal Gland NeoplasmsContext (language use)BiochemistryCohort StudiesYoung AdultEndocrinologyPancreatic tumorPituitary adenomaInternal medicineMultiple Endocrine Neoplasia Type 1medicineHumansPituitary NeoplasmsAge of OnsetChildMultiple endocrine neoplasiaGastrinomabusiness.industryBiochemistry (medical)Infantmedicine.diseasePancreatic NeoplasmsNeuroendocrine TumorsEndocrinologyChild PreschoolFemaleInsulinomaFranceAge of onsetbusinessCohort studyThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Contribution of thallium-201-SPECT to the grading of tumorous alterations of the brain

1992

Single photon emission computed tomography (SPECT) with thallium-201-chloride (201Tl) was used in 22 patients to assess the grade of malignancy of brain tumors. Low- and high-grade malignant gliomas could be well differentiated by calculating the Grade Index (GI), i.e., 201Tl uptake in the tumor area relative to a contralateral brain region. Low-grade gliomas (WHO-grade I-II) usually showed a GI of1.5. Tumors classified histologically as high-grade malignant (WHO-grade III-IV) had GI values greater than 1.42 and a mean value of 1.89. Until labelled amino-acid tracers for gamma-cameras become commercially available, thallium-201 brain-SPECT can provide an independent and complementary method…

AdenomaAdultMalemedicine.medical_specialtychemistry.chemical_elementAstrocytomaSingle-photon emission computed tomographyMalignancyDiagnosis DifferentialMeningeal NeoplasmsmedicineHumansPituitary NeoplasmsGrading (tumors)AgedNeoplasm StagingTomography Emission-Computed Single-Photonmedicine.diagnostic_testBrain Neoplasmsbusiness.industryBrainGliomaNeuroma AcousticGeneral MedicineMiddle Agedmedicine.diseaseThallium RadioisotopeschemistryPositron emission tomographyThalliumFemaleSurgeryNeurology (clinical)NeurosurgeryMeningiomabusinessNuclear medicineNeurosurgical Review
researchProduct

3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon.

2001

Despite the significance of tumour neoangiogenesis and the extensive knowledge on the molecular basis of blood vessel formation currently no quantitative data exist on the 3D microvascular architecture in human primary tumours and their precursor lesions. This prompted us to examine the 3D vascular network of normal colon mucosa, adenomas and invasive carcinomas by means of quantitative microvascular corrosion casting. Fresh hemicolectomy specimens from 20 patients undergoing cancer or polyposis coli surgery were used for corrosion casting, factor VIII and VEGF immunostaining. In addition, immunostaining was done on colorectal tissue from 33 patients with metastatic and non-metastatic carci…

AdenomaMaleVascular Endothelial Growth Factor ACancer ResearchPathologymedicine.medical_specialtytumour vascular architectureAdenomaAngiogenesisAdenomatous polyposis coliEndothelial Growth FactorsMetastasisNeovascularizationangiogenesisImage Processing Computer-AssistedMedicineHumansNeoplasm InvasivenessGrading (tumors)AgedLymphokinesbiologybusiness.industryVascular Endothelial Growth FactorsMicrocirculationCancerRegular ArticleMiddle Agedmedicine.diseasecolorectal adenocarcinomapre-cancerous lesionsOncologyAdenomatous Polyposis ColiColonic Neoplasmsbiology.proteinFemalemedicine.symptombusinessColorectal NeoplasmsPrecancerous ConditionsImmunostainingBritish journal of cancer
researchProduct

Tissue characterization of benign brain tumors: Use of NMR-tissue parameters

1988

Abstract To evaluate the potentials of NMR tissue parameters for tissue characterization we investigated 68 patients with benign brain tumors. Tissue parameters were accurately measured by a recently developed interlaced triple sequence. Each individual tumor was characterized by a set of three numbers (relaxation times T 1 and T 2 and proton density Rho). Different tumors exhibited significant overlaps of the three tissue parameters. Therefore a reliable prediction of the histological diagnosis based on the quantitative analysis of tissue parameters alone was not possible. T 2 -prolongation correlated well with water content and “regressive changes” in meningiomas and neuromas.

AdenomaPathologymedicine.medical_specialtyBrain NeoplasmsChemistryBiomedical EngineeringBiophysicsBenign brain tumorsBrainNeuroma AcousticTissue characterizationImage EnhancementMagnetic Resonance ImagingModels StructuralCraniopharyngiomaBody WaterHistological diagnosismedicineHumansPituitary NeoplasmsRadiology Nuclear Medicine and imagingMeningiomaProton densityQuantitative analysis (chemistry)Magnetic Resonance Imaging
researchProduct

Aminobisphosphonates as new weapons for gammadelta T Cell-based immunotherapy of cancer.

2008

BACKGROUND: Activated V gamma 9 V delta 2 T cells are able to kill most tumour cells because of recognition by T cell receptor and natural killer receptors. OBJECTIVE: We discuss the possibility that the intentional activation of gammadelta T cells in vivo by aminobisphosphonates may represent a promising target for the design of novel and highly innovative immunotherapy in cancer patients. METHODS: The antitumoral effects of gammadelta T cells both in vitro and in vivo have been demonstrated suggesting a new therapeutic approach for translation into the clinical setting. RESULTS/CONCLUSION: V gamma 9 V delta 2 T lymphocytes represent a particularly interesting target for immunotherapeutic …

Adjuvants ImmunologicDiphosphonatesCell Line TumorNeoplasmsT-LymphocytesProtein PrenylationAnimalsHumansReceptors Antigen T-Cell gamma-deltaImmunotherapyHuman gamma delta T cells tumors phosphoantigens bisphosphonates immunotherapyCurrent medicinal chemistry
researchProduct

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy

2018

Purpose This multicenter phase II trial evaluated lurbinectedin (PM01183), a selective inhibitor of active transcription of protein-coding genes, in patients with metastatic breast cancer. A unicenter translational substudy assessed potential mechanisms of lurbinectedin resistance. Patients and Methods Two arms were evaluated according to germline BRCA1/2 status: BRCA1/2 mutated (arm A; n = 54) and unselected ( BRCA1/2 wild-type or unknown status; arm B; n = 35). Lurbinectedin starting dose was a 7-mg flat dose and later, 3.5 mg/m2 in arm A. The primary end point was objective response rate (ORR) per Response Evaluation Criteria in Solid Tumors (RECIST). The translational substudy of resist…

Adult0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyGenes BRCA2Genes BRCA1Phases of clinical researchAntineoplastic AgentsBreast NeoplasmsHeterocyclic Compounds 4 or More RingsMice03 medical and health sciences0302 clinical medicineGermline mutationInternal medicineBiomarkers TumorClinical endpointAnimalsHumansMedicineProgression-free survivalGerm-Line MutationAgedDose-Response Relationship DrugErratabusiness.industryMiddle Agedmedicine.diseaseXenograft Model Antitumor AssaysMetastatic breast cancerProgression-Free SurvivalClinical trial030104 developmental biologyOncologyResponse Evaluation Criteria in Solid Tumors030220 oncology & carcinogenesisBiomarker (medicine)FemalebusinessCarbolinesJournal of Clinical Oncology
researchProduct